2026 ARTIFICIAL JOINT MANUFACTURER GUIDE
The artificial joint industry is no longer defined only by individual hip or knee implants. For distributors, hospital procurement teams and orthopedic sourcing professionals, the more important question is whether a manufacturer can provide a complete joint reconstruction portfolio covering primary replacement, revision surgery, compatible instruments, digital technologies and reliable long-term supply. This guide reviews 10 established artificial joint manufacturers in 2026 and compares their hip, knee, revision and surgical technology portfolios from a sourcing and market perspective.
Updated September 2026 · Manufacturer information checked against current company and product sources.
How to use this guide: This article is a market and sourcing overview rather than a clinical ranking of implant performance. Product availability, regulatory clearance and portfolio configuration can vary by country. Buyers should verify local registration, applicable indications and current product documentation before procurement.
Artificial Joint Manufacturers at a Glance
Artificial joint manufacturers increasingly compete across several dimensions at the same time: implant design, primary and revision coverage, surgical instrumentation, digital planning, robotic or navigation support, surgeon education and international distribution. The table below gives a quick view of the 10 companies covered in this guide.
| Manufacturer | Headquarters | Hip | Knee | Revision | Navigation / Robotics | Selected Systems |
| DePuy Synthes | United States | Yes | Yes | Yes | VELYS | CORAIL, ATTUNE |
| Zimmer Biomet | United States | Yes | Yes | Yes | ROSA | G7, Persona |
| Stryker | United States | Yes | Yes | Yes | Mako | Trident, Triathlon |
| Smith+Nephew | United Kingdom | Yes | Yes | Yes | CORI | POLAR3, JOURNEY, LEGION, LANDMARK |
| B. Braun Aesculap | Germany | Yes | Yes | Yes | OrthoPilot | Plasmafit, Columbus, VEGA |
| Enovis Surgical | United States | Yes | Yes | Yes | ARVIS | TaperFill, EMPOWR 3D Knee |
| MicroPort Orthopedics | United States / Global | Yes | Yes | Yes | SkyWalker | Evolution, Profemur |
| Medacta | Switzerland | Yes | Yes | Yes | NextAR | AMIS, GMK, NextAR Hip |
| Corin Group | United Kingdom | Yes | Yes | Yes | Apollo / OMNIBotics | Unity Knee, Trinity, Apex Revision |
| Waldemar LINK | Germany | Yes | Yes | Yes | — | LinkSymphoKnee, MP Reconstruction, Endo-Model |
What Is an Artificial Joint Manufacturer and Joint Prosthesis Supplier?
An artificial joint manufacturer designs and produces implants intended to replace all or part of a damaged natural joint. The terms artificial joint, joint implant and joint prosthesis are often used in overlapping ways, particularly in international procurement. In commercial orthopedic sourcing, a joint prosthesis manufacturer may supply femoral components, acetabular components, tibial trays, polyethylene inserts, femoral heads, stems, augments, cones and the corresponding surgical instrument systems.
Hip and knee reconstruction represent the largest and most developed areas of the artificial joint sector. However, the sourcing requirements can differ significantly between a simple primary replacement system and a complete joint reconstruction portfolio.
Primary Joint Replacement
Primary systems are intended for first-time joint replacement procedures and usually form the core volume business for hip and knee implant companies.
Revision Joint Replacement
Revision systems require greater modularity and more options for bone loss, fixation, stems, augments, cones and constrained reconstruction.
Implants and Instruments
For distributors, the commercial value of a joint line often depends on the complete implant-and-instrument ecosystem rather than the implant alone.
Buyers researching the broader supplier landscape can also see our comparison of joint implant manufacturers . For more specific brand comparisons, use the dedicated hip implant manufacturer guide and knee implant manufacturer guide .
Artificial Joint Market in 2026
The artificial joint market in 2026 is increasingly divided between high-volume primary arthroplasty and more complex reconstruction segments. Hip and knee replacement remain the core commercial categories, but manufacturers are expanding beyond standalone implants into revision systems, digital planning, navigation, robotics and patient-specific workflows.
One major development is the continued expansion of cementless fixation. Porous titanium structures, advanced coatings and implant geometries designed for biological fixation have expanded the range of cementless options in both hip and knee reconstruction. At the same time, revision portfolios are receiving more attention as the global installed base of primary joint replacements grows and healthcare systems manage increasingly complex reconstructive cases.
Technology is also changing how artificial joint companies compete. Navigation, handheld robotics, robotic-assisted systems, augmented reality and digital planning are becoming integrated with implant portfolios. DePuy Synthes, Zimmer Biomet, Stryker, Smith+Nephew, MicroPort, Medacta and Corin all provide some form of digital or technology-assisted workflow around joint replacement.
From a distributor perspective, this means the market is not determined only by the design of a femoral stem or knee component. Registration support, instrument availability, surgeon training, revision coverage, inventory requirements and supply continuity increasingly affect whether an artificial joint portfolio can be developed successfully in a local market.
Top 10 Artificial Joint Manufacturers in 2026
The following companies were selected for their established presence in hip and knee reconstruction, portfolio breadth, revision capabilities and continued investment in artificial joint technologies. The numbering is used to organize the guide and should not be interpreted as a clinical performance score.
1. DePuy Synthes
Hip Knee Revision VELYS Digital Surgery
DePuy Synthes, part of Johnson & Johnson MedTech, remains one of the most established artificial joint manufacturers with a broad orthopedic portfolio spanning hip, knee, reconstruction and enabling technologies.
Its hip portfolio includes the well-known CORAIL family and other primary and revision solutions, while the ATTUNE platform is central to its knee business. The ATTUNE range now includes cemented and cementless options as well as revision configurations, giving the company coverage across different stages of knee reconstruction.
A key development in 2026 was the U.S. commercial launch of VELYS Hip Navigation with AI Assistance. The system brings artificial intelligence-assisted image interpretation and intraoperative navigation into total hip arthroplasty, extending the company's digital orthopedic strategy beyond robotic-assisted knee replacement.
2. Zimmer Biomet
Hip Knee Revision ROSA Robotics
Zimmer Biomet has one of the most extensive portfolios in global joint reconstruction. Its product offering covers primary and revision hip and knee replacement, along with digital planning and robotic technologies.
The Persona Knee platform is designed around anatomical fit and includes cemented and cementless configurations. In hip reconstruction, the company offers multiple stem and acetabular platforms, including the G7 Acetabular System.
Zimmer Biomet has also expanded the ROSA platform across orthopedic workflows. ROSA Hip provides robotic assistance for direct anterior total hip arthroplasty and is compatible with multiple Zimmer Biomet hip systems. For buyers evaluating large integrated joint companies, the combination of implants, revision options and enabling technologies makes Zimmer Biomet an important benchmark.
3. Stryker
Hip Knee Revision Mako SmartRobotics
Stryker's joint replacement business combines a broad implant portfolio with one of the most visible robotic-assisted surgery platforms in orthopedics.
Its knee portfolio includes the Triathlon family, with primary, cementless, hinge and revision configurations. The hip portfolio includes Trident acetabular systems, multiple femoral stem options, dual mobility configurations and complex reconstruction solutions.
Mako is an important part of Stryker's competitive position. The platform supports both hip and knee workflows, and its hip capabilities have expanded from primary cases toward more complex reconstruction planning. This integrated approach illustrates a broader industry shift: leading artificial joint manufacturers increasingly develop implants and enabling technology as a connected ecosystem.
4. Smith+Nephew
Hip Knee Revision CORI Handheld Robotics
Smith+Nephew combines artificial joint implants with robotics, digital planning and advanced bearing technologies. Its current joint reconstruction portfolio covers both primary and revision hip and knee procedures.
Established systems include JOURNEY and LEGION in knee replacement, while hip solutions include primary and revision platforms such as POLAR3 and REDAPT. The company also integrates several knee workflows with the CORI handheld robotic platform.
In September 2026, Smith+Nephew announced FDA 510(k) clearance and the first surgical case using its new LANDMARK Total Knee System. The system was designed to work with CORI Knee Handheld Robotics, showing how the company continues to link new implant development with technology-assisted arthroplasty.
5. B. Braun Aesculap
Hip Knee Primary & Revision OrthoPilot Navigation
Aesculap is the orthopedic brand within the B. Braun group and should be considered as one integrated manufacturer rather than treated as two separate artificial joint companies.
The Aesculap hip portfolio includes cemented and cementless systems, the Plasmafit acetabular family and dedicated revision platforms. The knee portfolio includes systems such as Columbus, VEGA and revision configurations, with instrument solutions designed around the broader arthroplasty workflow.
Aesculap also offers the OrthoPilot navigation platform for orthopedic procedures. Its combination of implants, surgical instruments and navigation demonstrates a different type of integrated model compared with manufacturers that rely more heavily on large robotic capital equipment.
6. Enovis Surgical
Hip Knee Revision ARVIS Navigation
Enovis Surgical is the current surgical joint reconstruction business within Enovis and represents the evolution of the former DJO Surgical portfolio.
Its current hip offering includes the TaperFill Hip, EMPOWR acetabular and dual mobility solutions, as well as the EXPRT Revision Hip platform. In knee replacement, Enovis offers EMPOWR systems, including the EMPOWR 3D Knee and additional partial and total knee options.
Enovis also offers ARVIS, an augmented-reality-based navigation solution designed for orthopedic workflows. For distributors and healthcare systems, the company's combination of extremity reconstruction, large joints and surgical technologies gives Enovis a distinctive position within the wider orthopedic implant market.
7. MicroPort Orthopedics
Hip Knee Revision Robotics
MicroPort Orthopedics focuses strongly on hip and knee reconstruction and operates across an international distributor network. The company states that surgeons in more than 70 countries use its hip and knee products.
Its knee portfolio is particularly associated with medial-pivot design. The Evolution and Advance families cover primary and revision procedures, with cemented, cementless and constrained options available within the broader system architecture.
MicroPort's hip offering includes acetabular systems, femoral stems, revision options and tissue-sparing surgical approaches such as SuperPath. The company has also expanded into robotic-assisted orthopedic workflows through the SkyWalker platform.
8. Medacta
Switzerland Hip Knee NextAR
Medacta is a Swiss orthopedic company active in joint replacement, sports medicine and spine. Its joint business combines implant systems with surgical approaches, personalized planning and digital technologies.
The company has built a significant hip platform around AMIS and offers a broad selection of hip reconstruction solutions. Its knee business includes the GMK family and technology for personalized planning and execution.
One of the most important developments in 2026 was the introduction of NextAR Hip, an augmented reality navigation application for total hip arthroplasty. The system supports CT-based and CT-free workflows and expands Medacta's NextAR technology beyond knee, shoulder and spine procedures.
Medacta has also expanded patient-specific technologies for complex hip reconstruction, showing growing attention to cases beyond routine primary arthroplasty.
9. Corin Group
Hip Knee Revision Apollo / OMNIBotics
Corin Group combines hip and knee implants with a growing digital orthopedic ecosystem. The current portfolio includes primary and revision products as well as technologies for preoperative planning, robotic-assisted surgery and postoperative analysis.
In knee replacement, the company offers systems including Unity Knee and Apex Revision. Unity Knee can be used with the ApolloKnee robotic-assisted platform, while Corin also has experience with OMNIBotics robotic-assisted total knee arthroplasty.
Corin's hip portfolio includes primary and revision systems such as Trinity, MiniHip, MetaFix and Revival, together with dual mobility and digital planning technologies. This broad technology layer is increasingly relevant as artificial joint manufacturers compete on the full surgical pathway rather than implants alone.
10. Waldemar LINK
Germany Hip Knee Revision & Limb Salvage
Waldemar LINK is a German orthopedic implant manufacturer with long-standing experience in hip, knee, revision and complex reconstruction.
Its portfolio includes primary and revision hip systems such as the MP Reconstruction family, knee systems including LinkSymphoKnee and Endo-Model, and solutions for substantial bone loss and limb salvage. The LinkSymphoKnee platform extends from primary knee replacement into revision configurations with stems, augments and different levels of constraint.
LINK is particularly relevant when comparing manufacturers with deeper reconstruction portfolios, because revision, tumor and patient-specific implant solutions form a visible part of its product strategy rather than a small extension of a primary joint line.
Hip vs Knee Joint Manufacturers
A company can manufacture both hip and knee implants while still having very different strengths, product depth and distributor requirements in each category. For this reason, buyers should avoid treating all artificial joint manufacturers as interchangeable.
Hip Implant Manufacturers
Hip portfolios are typically evaluated by acetabular options, femoral stem philosophies, cemented and cementless fixation, bearing choices, dual mobility, revision reconstruction and instrument requirements.
Compare top hip implant manufacturers →
Knee Implant Manufacturers
Knee portfolios are often assessed by primary configurations, fixation method, constraint levels, patellar options, revision stems and augments, cones, hinge options and instrumentation.
Compare top knee implant manufacturers →
This distinction is important for SEO as well as procurement: this page provides the artificial joint manufacturer overview, while the dedicated hip and knee guides go deeper into the competitive landscape of each implant category.
How Distributors Should Evaluate an Artificial Joint Manufacturer
Selecting an artificial joint supplier is more complex than comparing implant catalogs. Joint replacement systems create long-term inventory, training, registration and instrument requirements. A distributor should therefore evaluate the complete commercial system.
1. Regulatory Coverage
Confirm which implants and instruments are registered in the target country and what technical documentation is available for local registration.
2. Portfolio Completeness
Review whether the supplier covers only one primary implant or provides a broader pathway from primary hip and knee systems to revision reconstruction.
3. Instrument Compatibility
Determine how many instrument sets are required, which components share instruments and whether replacement instruments can be supplied consistently.
4. Revision Capability
Revision systems can become important as the distributor's hospital base matures. Evaluate stems, augments, cones, constrained options and complex reconstruction coverage.
5. Manufacturing and QC
Review material controls, machining, inspection, traceability, packaging and quality systems rather than relying only on final product appearance.
6. Supply Continuity
Joint implant businesses require reliable replenishment of sizes and instruments. Lead time, inventory planning and continuity of product specifications matter.
7. Distributor Support
Catalogs, surgical techniques, instrument manuals, training materials and product matching support can significantly reduce the work required to establish a new joint line.
8. OEM and Private Label Capability
For buyers developing their own orthopedic brand, clarify packaging, labeling, documentation, MOQ, customization boundaries and registration responsibilities early.
Looking for an Artificial Joint Manufacturer in China?
Global orthopedic brands are useful benchmarks for product architecture and technology development, but distributors do not always need the same sourcing model as a multinational hospital group.
For importers and distributors looking for an artificial joint manufacturer in China, XC Medico provides hip and knee implant systems together with matched surgical instruments and distributor support.
The current XC Medico joint replacement portfolio includes cemented and cementless hip systems, primary and revision hip options, primary total knee systems, revision knee systems and hinged knee solutions.
- Hip and knee implants with matching surgical instruments
- Primary and revision joint replacement systems
- OEM / ODM and distributor cooperation options
- Product catalogs and product matching support
- Registration documentation support according to project requirements
- Implant manufacturing and quality-control capabilities
Buyers can review the implant manufacturing workshop and orthopedic implant quality-control process before discussing a sourcing project.
View Joint Systems Contact XC Medico
Artificial Joint Technology Trends in 2026
Artificial joint technology in 2026 is developing along several practical directions. The strongest changes are not isolated implant features; they involve the connection between implant systems, surgical planning and intraoperative execution.
Robotic and Navigation-Assisted Arthroplasty
Robotic and navigation technologies are becoming increasingly connected to specific implant ecosystems. Stryker's Mako, Zimmer Biomet's ROSA, Smith+Nephew's CORI and DePuy Synthes' VELYS illustrate different approaches to technology-assisted joint replacement.
In 2026, DePuy Synthes expanded VELYS into AI-assisted hip navigation, while Medacta introduced NextAR Hip using augmented reality. These developments suggest that digital assistance is moving beyond knee replacement into broader hip and joint reconstruction workflows.
Cementless Knee Replacement
Cementless fixation continues to receive attention as manufacturers expand porous structures, coatings and implant designs intended for biological fixation. Cementless options are now visible across several major knee portfolios rather than being confined to a small specialist segment.
For distributors, cementless systems can create new commercial opportunities but also require careful understanding of local surgeon preferences, indication mix, regulatory status and instrument compatibility.
Dual Mobility Hip Systems
Dual mobility is now an important part of many major hip portfolios. Manufacturers including Stryker, B. Braun Aesculap, Enovis and Corin provide dual mobility options within their acetabular systems.
From a sourcing perspective, buyers should evaluate whether dual mobility components are fully integrated with the supplier's cup, liner, head and instrument architecture rather than treating them as isolated SKUs.
Patient-Specific Planning and Digital Workflows
Personalized planning is developing through several routes: preoperative imaging, patient-specific guides, robotic planning, augmented reality and digital implant selection. The underlying commercial direction is similar — more manufacturers are connecting data and implants throughout the surgical pathway.
Primary-to-Revision Portfolio Integration
Another clear trend is portfolio continuity. Large joint manufacturers increasingly offer pathways that begin with primary arthroplasty and extend into revision stems, augments, cones, constrained knees and complex acetabular reconstruction.
This is particularly relevant for distributors. A primary-only system may be easier to launch, but hospitals often prefer suppliers that can support a wider range of cases as clinical demand develops.
Frequently Asked Questions About Artificial Joint Manufacturers
Who are the major artificial joint manufacturers?
Major artificial joint manufacturers include DePuy Synthes, Zimmer Biomet, Stryker, Smith+Nephew, B. Braun Aesculap, Enovis Surgical, MicroPort Orthopedics, Medacta, Corin Group and Waldemar LINK. Their portfolios vary by region and typically include different combinations of primary hip, knee, revision and surgical technology systems.
What companies manufacture hip and knee replacements?
Many established orthopedic companies manufacture both hip and knee replacements, including DePuy Synthes, Zimmer Biomet, Stryker, Smith+Nephew, B. Braun Aesculap, Enovis, MicroPort, Medacta, Corin and LINK. Buyers should evaluate the depth of each company's hip and knee portfolio separately because their strengths and system architecture differ.
What is the difference between a joint implant and a joint prosthesis?
In commercial orthopedic use, the terms often overlap. A joint prosthesis generally refers to the artificial components replacing part or all of a natural joint, while “joint implant” can be used more broadly for implantable orthopedic components. Buyers frequently use both terms when searching for artificial joint manufacturers.
How do distributors choose an artificial joint manufacturer?
Distributors should compare regulatory documentation, product range, primary and revision coverage, implant materials, instrumentation, manufacturing quality, supply continuity, training support and local market requirements. Price should be considered together with inventory and instrument costs rather than as a standalone factor.
Who manufactures artificial joints in China?
China has multiple manufacturers producing orthopedic joint implants for domestic and international markets. XC Medico supplies hip and knee replacement systems with corresponding instruments and supports international distributors with product matching, documentation and OEM / ODM cooperation.
What is the artificial joint market size?
Published estimates vary because market reports use different definitions, geographic scopes and product categories. Some include only large-joint replacement implants, while others also include extremities, instruments or enabling technologies. For procurement and market-entry decisions, buyers should check the definition and publication year of any market-size figure rather than relying on a single global estimate.
Editorial Accuracy Note
This guide is prepared for orthopedic distributors, importers, hospital procurement teams and industry researchers. Manufacturer information was reviewed using publicly available company and product information current to September 2026.
Product names, configurations, regulatory status and availability may change and may differ by country. Inclusion in this article does not represent a clinical recommendation or certification of one manufacturer's products over another. Healthcare professionals should refer to applicable product instructions for use and local regulatory requirements.
Sources and Update Notes
Key manufacturer and technology information was checked against current official sources, including:
- Johnson & Johnson MedTech / DePuy Synthes — ATTUNE Knee, CORAIL Hip and VELYS Hip Navigation. Official source
- Zimmer Biomet — Persona Knee, G7 Acetabular System and ROSA Hip. Official source
- Stryker — joint replacement portfolio, Triathlon, Trident and Mako. Official source
- Smith+Nephew — LANDMARK Total Knee, CORI, hip and knee reconstruction products. Official source
- B. Braun Aesculap — hip arthroplasty, knee arthroplasty, revision and OrthoPilot. Official source
- Enovis Surgical — TaperFill Hip, EMPOWR 3D Knee, revision hip and surgical technologies. Official source
- MicroPort Orthopedics — hip, knee, revision and robotics portfolios. Official source
- Medacta — joint reconstruction portfolio and NextAR Hip 2026 release. Official source
- Corin Group — hip, knee, revision and robotic-assisted orthopedic technologies. Official source
- Waldemar LINK — hip, knee, revision and limb salvage portfolio. Official source
Update history: Originally published May 8, 2025. Substantially rewritten in September 2026 to update the manufacturer list, separate B. Braun and Aesculap correctly as one group, update Enovis naming, expand the artificial joint market section, add distributor sourcing criteria and incorporate current 2026 joint replacement technologies.
Conclusion
The artificial joint manufacturing market is increasingly defined by complete reconstruction ecosystems rather than individual implants. Leading manufacturers now combine primary hip and knee systems with revision solutions, instruments, navigation, robotics or digital planning.
For distributors and importers, this changes the way suppliers should be compared. Product breadth, registration support, instrument architecture, revision coverage and supply continuity can be just as important as an individual implant design.
Buyers comparing international suppliers can use this page as the broad artificial joint manufacturer overview, then move to the dedicated hip, knee and joint implant manufacturer guides for category-specific research.
